Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹29,780.9
₹63,282 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,391.3
₹29,875 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹830.5
₹7,528 Cr
Pharmaceuticals & Drugs
₹464.9
₹7,316 Cr
Pharmaceuticals & Drugs
₹491.0
₹4,481 Cr
Pharmaceuticals & Drugs
₹302.0
₹3,380 Cr
Pharmaceuticals & Drugs
₹100.4
₹2,577 Cr
Pharmaceuticals & Drugs
₹805.1
₹459 Cr
Pharmaceuticals & Drugs
₹89.2
₹253 Cr
Pharmaceuticals & Drugs
₹46.8
₹228 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,391.3
₹4,806 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹464.9
₹4,123 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹491.0
₹2,422 Cr
Pharmaceuticals & Drugs
₹830.5
₹1,946 Cr
Pharmaceuticals & Drugs
₹302.0
₹668 Cr
Pharmaceuticals & Drugs
₹100.4
₹221 Cr
Pharmaceuticals & Drugs
₹46.8
₹85 Cr
Pharmaceuticals & Drugs
₹29,780.9
₹6,590 Cr
Pharmaceuticals & Drugs
₹805.1
₹327 Cr
Pharmaceuticals & Drugs
₹89.2
₹449 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,391.3
₹930 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹464.9
₹347 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹830.5
₹268 Cr
Pharmaceuticals & Drugs
₹491.0
₹189 Cr
Pharmaceuticals & Drugs
₹100.4
₹145 Cr
Pharmaceuticals & Drugs
₹302.0
₹139 Cr
Pharmaceuticals & Drugs
₹46.8
₹4 Cr
Pharmaceuticals & Drugs
₹29,780.9
₹1,452 Cr
Pharmaceuticals & Drugs
₹805.1
₹6 Cr
Pharmaceuticals & Drugs
₹89.2
₹4 Cr

You may also like the below Video Courses